Next Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Next Capital Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$549K	Hold	13,046	–	–	0.15%	82
2026 Q1	$345K	Hold	13,046	–	–	0.1%	100
2025 Q4	$378K	Hold	13,046	–	–	0.12%	91
2025 Q3	$362K	Hold	13,046	–	–	0.12%	92
2025 Q2	$318K	Buy	+13,046	New	+$286K	0.12%	101
2024 Q1	–	Sell	-6,716	Closed	-$220K	–	146
2023 Q4	$220K	Buy	+6,716	New	+$183K	0.09%	114
2023 Q3	–	Sell	-6,716	Closed	-$229K	–	117
2023 Q2	$229K	Hold	6,716	–	–	0.11%	107
2023 Q1	$202K	Buy	+6,716	New	+$208K	0.1%	114
2022 Q4	–	Sell	-6,716	Closed	-$221K	–	126
2022 Q3	$221K	Hold	6,716	–	–	0.17%	95
2022 Q2	$211K	Hold	6,716	–	–	0.15%	103
2022 Q1	$308K	Buy	+6,716	New	+$320K	0.21%	89

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Next Capital Management's ARKG Position: Q2 2026 in Review

Next Capital Management held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 13,046 shares worth $549K. The position accounts for 0.15% of the portfolio, ranked #82.

Next Capital Management first reported a position in ARKG in Q1 2022 and has held it in 11 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Next Capital Management held 13,046 shares of ARK Genomic Revolution ETF worth $549K as of Q2 2026.
Next Capital Management left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
ARK Genomic Revolution ETF made up 0.15% of Next Capital Management's portfolio in Q2 2026, its #82 holding.
Next Capital Management first reported a position in ARK Genomic Revolution ETF in Q1 2022 and has held it in 11 quarters since.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Next Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.